BioLineRx (BLRX) F-3 Shelf registration (foreign)

	Exhibit 12.1
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

																Nine Months ended September 30,
	2012			2013			2014			2015			2016			2017
EARNINGS
Pre-tax earnings from continuing operations		(19,163	)		(15,437	)		(9,955	)		(14,401	)		(15,841	)		(16,995	)
Add back:
Fixed charges		81			69			74			112			113			90
		(19,082	)		(15,368	)		(9,881	)		(14,289	)		(15,728	)		(16,905	)
FIXED CHARGES
Interest expensed and capitalized		5			-			-			2			4			3
Estimate of interest within rental expense		76			69			74			111			110			87
		81			69			74			112			113			90
RATIO OF EARNINGS TO FIXED CHARGES FOR F-3		(20,236	)		(16,301	)		(10,512	)		(14,401	)		(15,841	)		(16,995	)